397 related articles for article (PubMed ID: 26974154)
21. The Aberrant Expression of MicroRNA-125a-5p/IGF2BP3 Axis in Advanced Gastric Cancer and Its Clinical Relevance.
Zhang J; Ding F; Jiao D; Li Q; Ma H
Technol Cancer Res Treat; 2020; 19():1533033820917332. PubMed ID: 32266868
[TBL] [Abstract][Full Text] [Related]
22. Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia.
Folgiero V; Sorino C; Pallocca M; De Nicola F; Goeman F; Bertaina V; Strocchio L; Romania P; Pitisci A; Iezzi S; Catena V; Bruno T; Strimpakos G; Passananti C; Mattei E; Blandino G; Locatelli F; Fanciulli M
EMBO Rep; 2018 Mar; 19(3):. PubMed ID: 29367285
[TBL] [Abstract][Full Text] [Related]
23. Characterization of LEF1 High Expression and Novel Mutations in Adult Acute Lymphoblastic Leukemia.
Guo X; Zhang R; Liu J; Li M; Song C; Dovat S; Li J; Ge Z
PLoS One; 2015; 10(5):e0125429. PubMed ID: 25942645
[TBL] [Abstract][Full Text] [Related]
24. Deregulation of FGFR1 and CDK6 oncogenic pathways in acute lymphoblastic leukaemia harbouring epigenetic modifications of the MIR9 family.
Rodriguez-Otero P; Román-Gómez J; Vilas-Zornoza A; José-Eneriz ES; Martín-Palanco V; Rifón J; Torres A; Calasanz MJ; Agirre X; Prosper F
Br J Haematol; 2011 Oct; 155(1):73-83. PubMed ID: 21810092
[TBL] [Abstract][Full Text] [Related]
25. HoxA9 induces insulin-like growth factor-1 receptor expression in B-lineage acute lymphoblastic leukemia.
Whelan JT; Ludwig DL; Bertrand FE
Leukemia; 2008 Jun; 22(6):1161-9. PubMed ID: 18337761
[TBL] [Abstract][Full Text] [Related]
26. Differential expression of the novel oncogene, SALL4, in lymphoma, plasma cell myeloma, and acute lymphoblastic leukemia.
Cui W; Kong NR; Ma Y; Amin HM; Lai R; Chai L
Mod Pathol; 2006 Dec; 19(12):1585-92. PubMed ID: 16998462
[TBL] [Abstract][Full Text] [Related]
27. Expression profile, clinical significance, and biological function of insulin-like growth factor 2 messenger RNA-binding proteins in non-small cell lung cancer.
Shi R; Yu X; Wang Y; Sun J; Sun Q; Xia W; Dong G; Wang A; Gao Z; Jiang F; Xu L
Tumour Biol; 2017 Apr; 39(4):1010428317695928. PubMed ID: 28381175
[TBL] [Abstract][Full Text] [Related]
28. IMP-1 displays cross-talk with K-Ras and modulates colon cancer cell survival through the novel proapoptotic protein CYFIP2.
Mongroo PS; Noubissi FK; Cuatrecasas M; Kalabis J; King CE; Johnstone CN; Bowser MJ; Castells A; Spiegelman VS; Rustgi AK
Cancer Res; 2011 Mar; 71(6):2172-82. PubMed ID: 21252116
[TBL] [Abstract][Full Text] [Related]
29. The m6A reader IGF2BP3 promotes acute myeloid leukemia progression by enhancing RCC2 stability.
Zhang N; Shen Y; Li H; Chen Y; Zhang P; Lou S; Deng J
Exp Mol Med; 2022 Feb; 54(2):194-205. PubMed ID: 35217832
[TBL] [Abstract][Full Text] [Related]
30. Epigenetic silencing of the tumor suppressor microRNA Hsa-miR-124a regulates CDK6 expression and confers a poor prognosis in acute lymphoblastic leukemia.
Agirre X; Vilas-Zornoza A; Jiménez-Velasco A; Martin-Subero JI; Cordeu L; Gárate L; San José-Eneriz E; Abizanda G; Rodríguez-Otero P; Fortes P; Rifón J; Bandrés E; Calasanz MJ; Martín V; Heiniger A; Torres A; Siebert R; Román-Gomez J; Prósper F
Cancer Res; 2009 May; 69(10):4443-53. PubMed ID: 19435910
[TBL] [Abstract][Full Text] [Related]
31. Comparative genomics reveals multistep pathogenesis of E2A-PBX1 acute lymphoblastic leukemia.
Duque-Afonso J; Feng J; Scherer F; Lin CH; Wong SH; Wang Z; Iwasaki M; Cleary ML
J Clin Invest; 2015 Sep; 125(9):3667-80. PubMed ID: 26301816
[TBL] [Abstract][Full Text] [Related]
32.
Panebianco F; Kelly LM; Liu P; Zhong S; Dacic S; Wang X; Singhi AD; Dhir R; Chiosea SI; Kuan SF; Bhargava R; Dabbs D; Trivedi S; Gandhi M; Diaz R; Wald AI; Carty SE; Ferris RL; Lee AV; Nikiforova MN; Nikiforov YE
Proc Natl Acad Sci U S A; 2017 Feb; 114(9):2307-2312. PubMed ID: 28193878
[TBL] [Abstract][Full Text] [Related]
33. Aberrant Notch Signaling in the Bone Marrow Microenvironment of Acute Lymphoid Leukemia Suppresses Osteoblast-Mediated Support of Hematopoietic Niche Function.
Wang W; Zimmerman G; Huang X; Yu S; Myers J; Wang Y; Moreton S; Nthale J; Awadallah A; Beck R; Xin W; Wald D; Huang AY; Zhou L
Cancer Res; 2016 Mar; 76(6):1641-52. PubMed ID: 26801976
[TBL] [Abstract][Full Text] [Related]
34. Stabilization of oncogenic transcripts by the IGF2BP3/ELAVL1 complex promotes tumorigenicity in colorectal cancer.
Li K; Huang F; Li Y; Li D; Lin H; Ni R; Zhang Q; Zhao M; Huang S; Zou L; Huang C
Am J Cancer Res; 2020; 10(8):2480-2494. PubMed ID: 32905413
[TBL] [Abstract][Full Text] [Related]
35. m
Zhao Y; Zhou Y; Qian Y; Wei W; Lin X; Mao S; Sun J; Jin J
Clin Transl Med; 2024 Apr; 14(4):e1628. PubMed ID: 38572589
[TBL] [Abstract][Full Text] [Related]
36. Regulation of the MIR155 host gene in physiological and pathological processes.
Elton TS; Selemon H; Elton SM; Parinandi NL
Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
[TBL] [Abstract][Full Text] [Related]
37. PUMILIO/FOXP1 signaling drives expansion of hematopoietic stem/progenitor and leukemia cells.
Naudin C; Hattabi A; Michelet F; Miri-Nezhad A; Benyoucef A; Pflumio F; Guillonneau F; Fichelson S; Vigon I; Dusanter-Fourt I; Lauret E
Blood; 2017 May; 129(18):2493-2506. PubMed ID: 28232582
[TBL] [Abstract][Full Text] [Related]
38. Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells.
Drexler HG
Leukemia; 1996 Apr; 10(4):588-99. PubMed ID: 8618433
[TBL] [Abstract][Full Text] [Related]
39. Regulation of L-selectin expression by a dominant negative Ikaros protein.
Christopherson I; Piechoki M; Liu G; Ratner S; Galy A
J Leukoc Biol; 2001 Apr; 69(4):675-83. PubMed ID: 11310856
[TBL] [Abstract][Full Text] [Related]
40. HoxA9 transforms murine myeloid cells by a feedback loop driving expression of key oncogenes and cell cycle control genes.
Zhong X; Prinz A; Steger J; Garcia-Cuellar MP; Radsak M; Bentaher A; Slany RK
Blood Adv; 2018 Nov; 2(22):3137-3148. PubMed ID: 30463913
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
